Part of Fractional Precision Operations™

Free Professional Tools

Instant Insights. No Signup Required.

Each tool previews one of our premium products. Try them free to experience the quality and value before you buy.

📋 How to Use This Tool
Follow these steps to assess your country's readiness for clinical trial activation

🌍 Step 1: Select Country

Choose from 22 countries covering all major regulatory authorities. The tool will auto-populate known regulatory intelligence.

📝 Step 2: Fill Required Fields

Complete all fields marked with * (asterisk). The tool uses this data to calculate your readiness score.

🎯 Step 3: Generate Assessment

Click "Generate Intelligent Assessment" to receive your automated readiness score and actionable recommendations.

📊 Step 4: Review Results

Analyze your score, timeline estimate, and country-specific intelligence to make informed decisions.

🎯 Understanding Your Readiness Score (0-100)

🟢 80-100: High Readiness

Low risk. Proceed with confidence. Minimal barriers expected.

🟡 50-79: Moderate Readiness

Medium risk. Plan mitigation strategies for identified barriers.

🔴 0-49: Low Readiness

High risk. Consider alternative countries or extensive planning.

🔢 Scoring Algorithm

The tool starts with a base score of 100 and deducts points based on:

  • • Regulatory submission required (-10 points)
  • • Ethics review required (-5 points)
  • • Contracting not started (-15 points) or in progress (-5 points)
  • • Resource shortages present (-20 points)
  • • Complex special requirements (-10 points)
  • • Severe known barriers (-5 to -20 points based on severity)
Global Regulatory Readiness Scanner™
Intelligent assessment of regulatory complexity, barriers, and activation potential

Select the country where your study will be launched

Primary regulatory body overseeing clinical trials

Whether your study requires approval submission to national health authority

If ethics review by local or national IRB/EC is mandatory

Status of site contracts and legal agreements

Identify if shortages may impact clinical study setup

Any unique or additional requirements beyond standard submission

Describe roadblocks that may slow study setup in this region